naproxen tablet
1 INDICATIONS AND USAGE Naproxen tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets are also indicated for: the relief of signs and symptoms of: tendonitis bursitis acute gout the management of: pain primary dysmenorrhea Naproxen tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis Naproxen tablets are also indicated for: the relief of signs and symptoms of: tendonitis bursitis acute gout the management of: pain primary dysmenorrhea
exelan pharmaceuticals, inc.
Related Pills
naproxen tablet
exelan pharmaceuticals, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
NAPROXEN Tablets, USP: 250 mg: Light yellow, round, biconvex tablets de-bossed with ‘I’ on the left side of bisect and ‘G’ on the right side of bisect on one side and ‘340’ on the other, supplied in bottles of 100’s count (NDC 76282-340-01) and 500’s count (NDC 76282-340-05).
NAPROXEN Tablets, USP: 375 mg: Light pink, capsule shaped, biconvex tablets de-bossed with ‘IG’ on one side and ‘341’ on the other, supplied in bottles of 100’s count (NDC 76282-341-01) and 500’s count (NDC 76282-341-05).
NAPROXEN Tablets, USP: 500 mg: Light yellow, capsules shaped, biconvex tablets de-bossed with ‘I’ on the left side of bisect and ‘G’ on the right side of bisect on one side and ‘342’ on the other, supplied in bottles of 100’s count (NDC 76282-342-01) and 500’s count (NDC 76282-342-05). Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature]. Dispense in tight, light-resistant container.
More pills like ROUND I G 340